Adrian Kinkaid
Chief Executive Officer at FUSION ANTIBODIES PLC
Net worth: 25 877 $ as of 2024-03-30
Profile
Adrian Kinkaid is currently the Chief Executive Officer & Director at Fusion Antibodies Plc since 2022.
Prior to this, he was the Chief Executive Officer at MIP Discovery Ltd.
(United Kingdom) from 2015 to 2022.
Dr. Kinkaid holds a doctorate degree from The University of Southampton.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FUSION ANTIBODIES PLC
0.57% | 2024-02-13 | 546,272 ( 0.57% ) | 25 877 $ | 2024-03-30 |
Adrian Kinkaid active positions
| Companies | Position | Start |
|---|---|---|
| FUSION ANTIBODIES PLC | Chief Executive Officer | 2022-08-14 |
Former positions of Adrian Kinkaid
| Companies | Position | End |
|---|---|---|
MIP Discovery Ltd. (United Kingdom)
 MIP Discovery Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom. | Chief Executive Officer | 2022-08-14 |
Training of Adrian Kinkaid
| The University of Southampton | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FUSION ANTIBODIES PLC | Health Services |
| Private companies | 1 |
|---|---|
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Adrian Kinkaid
